Advanced Micro Device passed Wall Street’s test with its latest earnings report and commentary. Now investors are hungry for more substantial information, which could come next week at the company’s ...
Almost exactly one year ago, Janux Therapeutics unveiled early data for its investigational T-cell engager that wowed investors and analysts alike. But the biotech’s newest update has failed to garner ...
Mixpanel said an attacker accessed part of its systems and exported customer-identifiable metadata. OpenAI said no prompts, API keys, payment information, or authentication tokens were involved. Both ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback